/PRNewswire/ Given the growing cannabidiol (CBD) products market, the U.S. Food and Drug Administration convened a high-level internal working group to.
(Reuters) - The U.S. Food and Drug Administration said on Thursday it does not intend to make any new guidance on the use of the popular cannabis compound CBD in
(Reuters) - The U.S. Food and Drug Administration said on Thursday it does not intend to make any new guidance on the use of the popular cannabis comp.
(Reuters) - The U.S. Food and Drug Administration said on Thursday it does not intend to make any new guidance on the use of the popular cannabis comp.